Thermo Fisher Scientific (TMO) is Reiterated by Mizuho to Buy, Raises Price Target to $ 166

Thermo Fisher Scientific (TMO) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 166 from a previous price target of $163 . Mizuho advised their investors in a research report released on May 19, 2016.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .

On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.

Thermo Fisher Scientific opened for trading at $147.9 and hit $150.43 on the upside on Monday, eventually ending the session at $150.24, with a gain of 1.59% or 2.35 points. The heightened volatility saw the trading volume jump to 14,73,044 shares. Company has a market cap of $59,121 M.

In a different news, on May 17, 2016, Peter E Hornstra (VP & Chief Accounting Officer) sold 7,811 shares at $150.00 per share price. According to the SEC, on Apr 27, 2016, Daniel P Shine (Senior Vice President) sold 6,013 shares at $146.00 per share price. On Apr 7, 2016, Seth H Hoogasian (Sr. VP, Gen. Counsel & Sec.) sold 10,000 shares at $142.05 per share price, according to the Form-4 filing with the securities and exchange commission.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Thermo Fisher Scientific

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.